Šajā tīmekļa vietnē tiek izmantotas sīkdatnes. Turpinot lietot šo vietni, jūs piekrītat sīkdatņu izmantošanai. Uzzināt vairāk.
Teksta versija
LATVIJAS REPUBLIKAS TIESĪBU AKTI
uz sākumu
Izvērstā meklēšana
Autorizēties savā kontā

Kādēļ autorizēties vai reģistrēties?
 

COUNCIL OF EUROPE No 135A

ANTI-DOPING CONVENTION

Strasbourg, 16.11.1989

Preamble

The member States of the Council of Europe, the other States party to the European Cultural Convention, and other States, signatory hereto,

Considering that the aim of the Council of Europe is to achieve a greater unity between its members for the purpose of safeguarding and realising the ideals and principles which are common heritage and of facilitating their economic and social progress;

Conscious that sport should play an important role in the protection of health, in moral and physical education and in promoting international understanding;

Concerned by the growing use of doping agents and methods by sportsmen and sports women throughout sport and the consequences thereof for the health of participants and the future of sport;

Mindful that this problem puts at the risk the ethical principles and educational values embodied in the Olympic Charter, in the International Charter for Sport and Physical Education of UNESCO and in Resolution (76) 41 of the Committee of Ministers of the Council of Europe, known as the "European Sports for All Charter'';

Bearing in mind the anti-doping regulations, policies and declarations adopted by the International sports organisations;

Aware that public authorities and voluntary sports organisations have complementary responsibility to combat doping in sport, notably to ensure the proper conduct, on the basis of the principles of fair play, of the sports events and to protect the health of those that take part in them;

Recognising that these authorities and organisations must work together for these purposes at all appropriate levels;

Recalling the resolutions on doping adopted by the Conference of the European Ministers responsible for Sport, and in particular Resolution No. 1 adopted at the 6th Conference at Reykjavik in 1989;

Recalling that the Committee of Ministers of the Council of Europe has already adopted Resolution (67) 12 on the doping of athletes, Recommendation Nr. R (79) 8 on doping in sport, Recommendation Nr. R (84) 19 on the "European Anti-doping Charter for Sport" and Recommendation Nr. R (88) 12 on the institution of doping controls without warning outside competitions;

Recalling Recommendation Nr. 5 on doping adopted by the 2nd International Conference of Ministers and Senior Officials responsible for Sport and Physical Education organised by UNESCO at Moscow (1988);

Determined however to take further and stronger co-operative action aimed at the reduction and eventual elimination of doping in sport using as a basis the ethical values and practical measures contained in those instruments;

Have agreed as follows:

Article 1

Aim of the Convention

The Parties, with a view to the reduction and eventual elimination of doping use in sport, undertake, within the limits of their respective constitutional provisions, to take the steps necessary to apply the provisions of this Convention.

Article 2

Definition and scope of the Convention

1. For the purposes of this Convention:

a. "doping in sport" means the administration to sportsmen or sportswomen, or the use by them, of pharmacological classes of doping agents or doping methods;

b. "pharmacological classes of doping agents or doping methods" means, subject to paragraph 2 below, those classes of doping agents or doping methods banned by the relevant international sports organisations and appearing in lists that have been approved by the Monitoring Group under the terms of Article 11.1.b;

c. "sportsmen and sportswomen" means those persons who participate regularly in organised sports activities.

2. Until such time as al it of banned pharmacological classes of doping agents and doping methods is approved by the Monitoring Group under the terms of the article 11.1.b, the reference list in the appendix to this Convention shall apply.

Article 3

Domestic co-ordination

1. The Parties shall co-ordinate the policies and actions of their government departments and other public agencies concerned with combating doping in sport.

2. They shall ensure that there is practical application of this Convention, and in particular that the requirements under Article 7 are met, by entrusting, where appropriate, in implementation of some of the provisions of this Convention to a designed governmental or non-governmental sports authority or to a sports organisation.

Article 4

Measures to restrict the availability and use of banned doping agents and methods

1. The Parties shall adopt where appropriate legislation, regulations or administrative measures to restrict the availability (including provisions to control movement, possession, importation, distribution and sale) as well as the use in sport of banned doping agents and doping methods and, in particular, anabolic steroids.

2. To this end, the Parties or, where appropriate, the relevant non-governmental organisation shall make it a criterion for the grant of public subsidies to sports organisations that they effectively apply anti-doping regulations.

3. Furthermore, the Parties shall:

a. assist their sports organisations to finance doping controls and analyses, either by direct subsidies or grants, or by recognising the costs of such controls and analyses when determining the overall subsidies or grants to be awarded to those organisations;

b. take appropriate steps to withhold the grant of subsidies from public funds, for training purposes, to individual sportsmen and sportswomen who have been suspended following a doping offence in sport, during the period of their suspension.

c. encourage and, where appropriate, facilitate the carrying out by their sports organisations of the doping controls required by the competent international sports organisations whether during or outside competitions; and

d. encourage and facilitate the negotiation by sports organisations of agreements permitting their members to be tested by duly authorised doping control teams in other countries.

4. Parties reserve the rights to adopt anti-doping regulations and to organise doping controls on their own initiative and on their own responsibility, provided that they are compatible with the relevant principles of this Conventions.

Article 5

Laboratories

1. Each Party undertakes:

a. either to establish or facilitate the establishment on its territory of one or more doping control laboratories suitable for consideration for accreditation under the criteria adopted by the relevant international sports organisations and approved by the Monitoring Group under the terms of Article 11.1.b; or

b. to assist it sports organisations to gain access to such laboratory on the territory of another Party.

2. These laboratories shall be encouraged to:

a. take appropriate action to employ and retain, train and retrain qualified staff;

b. undertake appropriate programmes of research and development into doping agents and methods used, or thought to be used, for purposes of doping in sport and into analytical biochemistry and pharmacology with a view to obtaining a better understanding of the effects of various substances upon the human body and their consequences for the athletes performance;

c. publish and circulate promptly new data from their research.

Article 6

Education

1. The Parties undertake to devise and implement, where appropriate in co-operation with the sports organisations concerned and the mass media, educational programmes and information campaigns emphasising the danger to health inherent in doping and its harm to the ethical values of sport. Such programmes and campaigns shall be directed at both young people in schools and sports clubs and their parents and adult sportsmen and sportswomen, sports official, coaches and trainers. For those involved in medicine, such educational programmes will emphasise respect for medical ethics.

2. The Parties undertake to encourage and promote research, in co-operation with regional, national and international sports organisations concerned, into ways and means of devising scientifically-based physiological and psychological training programmes that respect the integrity of the human person.

Article 7

Co-operation with sports organisations on measures to be taken by them

1. The Parties undertake to encourage their sports organisations and trough them the international sports organisations to formulate and apply all appropriate measures, falling within their competence, against doping in sport.

2. To this end, they shall encourage their sports organisations to clarify and harmonise their respective rights, obligations and duties, in particular by harmonising their:

a. anti-doping regulations on the basis of the regulations agreed by the relevant international sports organisations

b. lists of banned pharmacological classes of doping agents and banned doping methods on the basis of the lists agreed by the relevant international sports organisations;

c. doping control procedures;

d. disciplinary procedures, applying agreed international principles of natural justice and ensuring respect for the fundamental rights of suspected sportsmen and sportswomen; these principles will include:

i. the reporting and disciplinary bodies to be distinct from one another;

ii. the right of such persons to a fair hearing and to be assisted or represented;

iii. clear and enforceable provisions for appealing against any judgement made;

e. procedures for imposition of effective penalties for officials, doctors, veterinary doctors, coaches, physiotherapists and other officials or accessories associated with infringements of the anti-doping regulations by sportsmen and sportswomen;

f. procedures for the mutual recognition of suspensions and other penalties imposed by other sports organisations in the same or other countries.

3. Moreover, the Parties shall encourage their sports organisations:

a. to introduce, on an effective scale, doping controls not only at, but also without advance warning at any appropriate time outside, competitions, such controls to be conducted in a way which is equitable for all sportsmen and sportswomen and which includes testing and retesting of persons selected, where appropriate, on a random basis;

b. to negotiate agreements with sports organisations of other countries permitting a sportsman or sportswomen training in another country to be tested by a duly authorised doping control team of that country;

c. to clarify and harmonise regulations on eligibility to take part in sports events which will include anti-doping criteria;

d. to promote active participation by sportsmen and sportswomen themselves in the anti-doping work of international sports organisations;

e. to make full and efficient use of the facilities available for doping analysis at the laboratories provided by Article 5, both during and outside sports competitions;

f. to study scientific training methods and to devise guidelines to protect sportsmen and sportswomen of all ages, appropriate for each sport.

Article 8

International co-operation

1. The Parties shall co-operate closely on the matters covered by this Convention and shall encourage similar co-operation amongst their sports organisations.

2. The Parties undertake:

a. to encourage their sports organisations to operate in a manner that promotes application of the provisions of this Convention within all the appropriate international sports organisations to which they are affiliated, including the refusal to ratify claims for the world or regional records unless accompanied by an authenticated negative doping control report;

b. to promote co-operation between the staffs of their doping control laboratories established or operating in pursuance of Article 5; and

c. to initiate bilateral and multilateral co-operation between their appropriate agencies, authorities and organisations in order to achieve, at the international level as well, the purposes set out in Article 4.1.

3. The Parties with laboratories established or operating in pursuance of Article 5 undertake to assist other Parties to enable them to acquire the experience, skills and techniques necessary to establish their own laboratories.

Article 9

Provision of information

Each Party shall forward to Secretary General of the Council of Europe, in one of the official languages of the Council of Europe, all relevant information concerning legislative and other measures taken by it for the purpose of complying with the terms of this Convention.

Article 10

Monitoring Group

1. For the purposes of this Convention, a Monitoring Group is hereby set up.

2. Any Party may be represented on the Monitoring Group by one or more delegates. Each Party shall have one vote.

3. Any State mentioned in Article 14.1 which is not a Party to this Convention may be represented on the Monitoring Group by an observer.

4. The Monitoring Group may, by unanimous decision, invite any non-member State of the Council of Europe which is not a Party of this Convention and any sports or other professional organisation concerned to be represented by an observer at one or more of its meetings.

5. The Monitoring Group shall be convened by Secretary General. Its first meeting shall be held as soon as reasonably practicable, and in any case within one year after the date of the entry into force of the Convention. It shall be subsequently meet whenever necessary, on the initiative of the Secretary General.

6. A majority of the Parties shall constitute a quorum for holding a meeting of the Monitoring Group.

7. The Monitoring Group shall meet in private.

8. Subject to the provisions of this Convention, the Monitoring Group shall draw up and adopt by consensus its own Rules of Procedures.

Article 11

1. The Monitoring Group shall monitor the application of this Convention. It may in particular:

a. keep under review the provisions of this Convention and examine any modifications necessary;

b. approve the list, and any revision thereto, of pharmacological classes of doping agents and doping methods banned by the relevant international sports organisations, referred in to Articles 2.1. and 2.2., and the criteria for accreditation of laboratories, and any revision thereto, adopted by said organisations, referred to in Article 5.1.a, and fix the date for the relevant decisions to enter into force;

c. hold consultations with relevant sports organisations;

d. make recommendations to the Parties concerning measures to be taken for the purposes of this Convention;

e. recommend the appropriate measures to keep relevant international sports organisations and the public informed about the activities undertaken within the framework of this Convention;

f. make recommendations to the Committee of Ministers concerning non-member States of the Council of Europe to be invited to accede to this Convention;

g. make any proposal for improving the effectiveness of this Convention.

2. In order to discharge its functions, the Monitoring Group may, on its own initiative, arrange for meetings of groups of experts.

Article 12

After each meeting, the Monitoring Group shall forward to the Committee of Ministers of the Council of Europe a report on its work and on the functioning of the Convention.

Article 13

Amendments to the Articles of the Convention

1. Amendments to the Articles of this Convention may be proposed by a Party, the Committee of Ministers of the Council of Europe or the Monitoring Group.

2. Any proposal for amendment shall be communicated by the Secretary General of the Council of Europe to the States mentioned in Article 14 and to every State which acceded to or has been invited to accede to this Convention in accordance with the provisions of Article 14.

3. Any amendment proposed by a Party or the Committee of Ministers shall be communicated to the Monitoring Group at least two months before the meeting at which it is to be considered. The Monitoring Group shall submit to the Committee of Ministers its opinion on the proposed amendment, where appropriate after the consultations with the relevant sports organisations.

4. The Committee of Ministers shall consider the proposed amendment and any opinion submitted by the Monitoring Group and may adopt the amendment.

5. The text of any amendment adopted by Committee of Ministers in accordance with paragraph 4 of this Article shall be forwarded to the Parties for acceptance.

6. Any amendment adopted in accordance with paragraph 4 of this Article shall come into force on the first day of the month following the expiration of a period of one month after all Parties have informed the Secretary General of their acceptance thereof..

Final clauses

Article 14

1. This Convention shall be opened for signature by member States of the Council of Europe, other States party to the European Culture Convention and non-member States which have participated in the elaboration of this Convention, which may express their consent to be bound by:

a. signature without reservation as to ratification, acceptance or approval, or

b. signature subject to ratification, acceptance or approval, followed by ratification, acceptance or approval.

2. Instruments of ratification, acceptance or approval shall be deposited with the Secretary General of the Council of Europe.

Article 15

1. The Convention shall enter into force on the first day of the month following the expiration of a period of one month after the date on which five States, including at least four member States of the Council of Europe, have expressed their consent to be bound by the Convention in accordance with the provisions of Article 14.

2. In respect of any signatory State which subsequently expresses its consent to be bound by it, the Convention shall enter into force on the first day of the month following the expiration of a period of one month after the date of signature or of the deposit of the instrument of ratification, acceptance or approval.

Article 16

1. After the entry into force of this Convention, the Committee of Ministers of the Council of Europe, after consulting the Parties, may invite to accede to the Convention any non-member State by a decision taken by the majority provided in Article 20.d of the Statute of the Council of Europe and by the unanimous vote of representatives of Contracting States entitled to sit on the Committee.

2. In respect of any acceding State, the Convention shall enter into force on the first day of the month following the expiration of a period of one month after the date of deposit of the instrument of accession with the Secretary General of Council of Europe.

Article 17

1. Any State may, at the time of signature or when deposing its instrument of ratification, acceptance or approval, specify the territory or territories to which this Convention shall apply.

2. Any State may, at later date, by a declaration addressed to the Secretary General of the Council of Europe, extend the application of this Convention to any other territory specified in the declaration. In respect of such territory the Convention shall enter into force on the first day of the month following the expiration of a period of one month after the date of receipt of such declaration by the Secretary General.

3. Any declaration made under two preceding paragraphs may, in respect of any territory mentioned in such declaration, be withdrawn by a notification addressed to the Secretary General. Such withdrawal shall become effective on the first day of the month following the expiration of a period of six month after the date of receipt of the notification by the Secretary General.

Article 18

1. Any Party, at any time, denounce this Convention by means of notification addressed to the Secretary General of the Council of Europe.

2. Such denunciation shall become effective on the first day of the month following the expiration of a period of six month after the date of receipt of the notification by the Secretary General.

Article 19

The Secretary General of the Council of Europe shall notify the Parties, the other member States of the Council of Europe, the other States party to the European Culture Convention and any State which has acceded or has been invited to accede to it of:

a. any signature in accordance with Article 14;

b. the deposit of any instrument of ratification, acceptance or approval in accordance with Article 14 or 16;

c. any date of entry into force of this Convention in accordance with Article 15 and 16;

d. any information forwarded under the provision of Article 9;

e. any report prepared in pursuance of the provisions of Article 12;

f. any proposal for amendment or any amendment adopted in accordance with Article 13 an the date on which the amendment comes into force;

g. any declaration made under the provision of Article 17;

h. any notification made under the provision of Article 18 and the date on which the denunciation takes effect;

i. any other act, notification or communication relating to this Convention.

In witness whereof the undersigned, being duly authorised thereto, have signed this Convention.

Done at Strasbourg, this 16th day of November 1989, in English and in French, both texts being equally authentic, in a single copy which shall be deposited in the archives of the Council of Europe. The Secretary General of the Council of Europe shall transmit certified copies to each member State of the Council of Europe, to the other States party to the European Culture Convention, to non-member States which have participated in the elaboration of this Convention and to any State invited to accede to it.

 

APPENDIX

Reference list of pharmacological classes of doping agents and doping methods

I

Doping classes

 

A. Stimulants

 

B. Narcotics

 

C. Anabolic Steroids

 

D. Beta-blockers

 

E. Diuretics

 

F. Peptide hormones and analogues

II

Doping methods

 

A. Blood doping

 

B. Pharmacological, chemical and physical manipulation

III

Classes of drugs subject to certain restriction

 

A. Alcohol

 

B. Marijuana

 

C. Local anaesthetics

 

D. Corticosteroids

Examples

 

I

Doping classes

 

A. Stimulants e.g.:

   

amfepramone

   

amfetaminil

   

amiphenazole

   

amphetamine

   

benzphetamine

   

caffeine*

   

cathine

   

chlorphentermine

   

clorbenzorex

   

clorprenaline

   

cocaine

   

croprompamide (component of "micoren")

   

crothetamide (component of of "micoren")

   

dimetamphetamine

   

ephedrine

   

ethamivan

   

etilamphetamine

   

fencamfamin

   

fenetylline

   

fenproporex

   

furfenorex

   

mefenorex

   

methamphetamine

   

methoxyphenamine

   

methylephedrine

   

methylphenidate

   

morazone

   

nikethamide

   

pemoline

   

pentetrazol

   

phendimetrazine

   

phentermine

   

phenylpropanolamine

   

pipradol

   

prolintane

   

propylhexedrine

   

pyrovalerone

   

strychnine

and related compounds

  * For caffeine, the definition of a positive depends upon the following: - If the concentration in urine exceeds 12 micrograms/ml.
 

B. Narcotics analgesics e.g.:

 
   

alphaprodine

   

anileridine

   

buprenorphine

   

codeine

   

dextromoramide

   

dextropropoxyphene

   

diamorphine (heroin)

   

dihydrocodeine

   

dipipanone

   

ethoheptazine

   

ethymorphine

   

levorphanol

   

methadone

   

morphine

   

nalbuphine

   

pentazocine

   

pethidine

   

phenazocine

   

trimeperidine

and related compounds
     
 

C. Anabolic steroids e.g.:

 
   

bolasterone

   

boldenone

   

clostebol

   

dehydrochlor-methyltestosterone

   

fluoxymesterone

   

mesterolone

   

metandienone

   

metenolone

   

methyltestosterone

   

nandrolone

   

norethandrolone

   

oxandrolone

   

oxymestrone

   

oxymetholone

   

stanozolol

   

testosterone *

and related compounds

* For testosterone, the definition of a positive depends upon the following: - the administration of testosterone or use of any other manipulation having the

result of increasing the ratio in urine of testosterone/epitestosterone to above 6.

 

D. Beta-blockers e.g.:

 
   

acebutolol

   

alprenolol

   

atenolol

   

labetalol

   

metorpolol

   

nadolol

   

oxprenolol

   

propranolol

   

sotalol

and related compounds

   

 

 

E. Diuretics e.g.:

 
   

acetazolamide

   

amiloride

   

bendroflumethiazide

   

benzthiazide

   

bumetadine

   

canrenone

   

chlormerodrin

   

chlortalidone

   

diclofenamide

   

ethacrynic acid

   

furosemide

   

hydrochlorthiazide

   

mersalyl

   

spironolactone

   

triamterene

and related compounds

 

F. Peptide hormones and analogues

 
   

Chorionic Gonadotrophin (HCG - human chorionic gonadothropin)

   

Corticotrophin (ACTH)

   

Growth hormone (HGH, somatotrophin)

II

Doping methods

 
 

A. Blood doping

 
 

B. Pharmacological , chemical and physical manipulation

 

III

Classes of drugs subject to certain restriction

 
 

A. Alcohol

 
 

B. Marijuana

 
 

C. Local anaesthetics

 
 

D. Corticosteroids

 

Note:
The above list is the list of Doping Classes of Methods as adopted by the International Olympic Committee in April 1989.

T-DO (96) 25
Appendix to letter JJ 3638C
of 27 August 1996

Amendment to the Appendix 1

Adopted at the 7th Meeting of the Monitoring Group
(30-31 May 1996)
Entered into force 1 July 1996

Reference list of pharmocological classes of doping agents and doping methods

I

PROHIBITED CLASSES OF SUBSTANCES

A. Stimulants

B. Narcotics

C. Anabolic Agents

D. Diuretics

E. Peptide and glycoprotein hormones and analogues

II

PROHIBITED METHODS

A. Blood doping

B. Pharmaceutical, chemical and physical manipulation

III

CLASSES OF DRUGS SUBJECT TO CERTAIN RESTRICTION

A. Alcohol

B. Marijuana

C. Local anaesthetics

D. Corticosteroids

E. Beta-blockers

Article I

PROHIBITED CLASSES OF SUBSTANCES

Prohibited substances fall into following classes of substances:

A. Stimulants

B. Narcotics

C. Anabolic Agents

D. Diuretics

E. Peptide and glycoprotein hormones and analogues

A. Stimulants

 

Prohibited substances in class (a) include the following examples

 

amiphenazole

amphetamines

amineptine

caffeine

 

cocaine

ephedrine

fencamfamine

mesocarb

 

pentylentetrazol

pipradol

salbutamol

terbutaline

 

salmeterol

     
 

and related substances

     

B. Narcotics

 

Prohibited substances in class (b) include the following examples

     
 

dextromoramide

dextropropoxyphene

diamorphine(heroin)

methadone

 

morphine

pentazocine

pethidine

 
 

and related substances

     

Note: Codeine, dextromethorphan, dihydrocodeine, diphenoxylate and pholcodine are permitted

C. Anabolic Agents

The Anabolic class includes anabolic androgenic steroids (AAS) and Beta-2 agonists.

 

Prohibited substances in class (c) include the following examples

   
 

1. Anabolic androgenic steroids

     
 

clostebol

fluoxymestrerone

metandienone

metenolone

 

nandrolone

oxandrolone

stanozolol

testosterone

 

and related substances

     
 

2. Beta-2 agonists

     
 

clenbuterol

salbutamol

terbutaline

salmeterol

  fenoterol      
 

and related substances

     

D. Diuretics

 

Prohibited substances in class (d) include the following examples

     

acetazolamide

bumetanide

chlorthalidone

ethacrynic acid

 

furosemide

hydrochlorthiazide

mannitol

mersalyl

 

spironolactone

triamterene

     
 

and related substances

     

E. Peptide and glycoprotein hormones and analogues

 

Prohibited substances in class (e) include the following examples

     
 

1. Chorionic Gonadotrophin (HCG - human chorionic gonadothropin)

     
 

2. Corticotrophin (ACTH)

     
 

3. Growth hormone (HGH, somatotrophin)

     
 

and all the respective releasing factors for such substances

     
 

4. Erythropoietin (EPO)

     

Article II

PROHIBITED METHODS

Blood doping

Pharmaceutical, chemical and physical manipulation

Article III

CLASSES OF DRUGS SUBJECT TO CERTAIN RESTRICTION

A. Alcohol

B. Marijuana

C. Local anaesthetics

Injectable local anaesthetics are permitted under the following condition:

a) that bupivacaine, lidocaine, mepivacaine, procaine, etc., are used but not cocaine. Vasoconstrictor agents (e.g. adrenaline) may be used in conjunction with local anaesthetics;

b) only local or intra-articular injections may be administered;

c) only when medically justified (e.g. the details including diagnosis) dose and route of administration must be submitted prior the competition or immediately, if administered during the competition, in writing to the relevant medical authority.

D. Corticosteroids

The use of corticosteroids is banned except:

a) for topical use (aural, dermatological and ophtalmological but not rectal);

b) by inhalation;

c) by intra-articular or local injections.

E. Beta-blockers

Some examples of beta-blockers are:

 

acebutolol

alprenolol

atenolol

labetalol

 

metoprolol

nadolol

oksprenolol

propranolol

 

sotalol

   
 

and related substances

   

 

_______________________________________

1 Previously amended on 1 September 1990, on 24 January 1992 and on 1 August 1993.

 
Tiesību akta pase
Statuss:
Spēkā esošs
Spēkā esošs
Starpt. org.:
Veids:
 starptautisks dokuments
 daudzpusējs
Pieņemts:
 16.11.1989.
Stājas spēkā:
 01.03.1997.
Parakstīts:
 23.01.1997.
Pievienošanās:
 23.01.1997.
Pieņemšanas vieta: 
Strasbūra
Ratificēja:
 Saeima
Atruna: Nav
Deklarācija: Nav
Depozitārijs:
 Eiropas Padome
Publicēts:
 "Latvijas Vēstnesis", 1/2, 03.01.1997.
Dokumenta valoda:
Saistītie dokumenti
  • Paziņojums par spēkā stāšanos
  • Grozījumi
  • Citi saistītie dokumenti
1172
0
  • Twitter
  • Facebook
  • Draugiem.lv
 
0
Šajā vietnē oficiālais izdevējs
"Latvijas Vēstnesis" nodrošina tiesību aktu
sistematizācijas funkciju.

Visam Likumi.lv saturam ir informatīvs raksturs.
Par Likumi.lv
Aktualitātes
Noderīgas saites
Atsauksmēm
Kontakti
Mobilā versija
Lietošanas noteikumi
Privātuma politika
Sīkdatnes
Latvijas Vēstnesis "Ikvienam ir tiesības zināt savas tiesības."
Latvijas Republikas Satversmes 90. pants
© Oficiālais izdevējs "Latvijas Vēstnesis"
ISO 9001:2015 (kvalitātes vadība)
ISO 27001:2013 (informācijas drošība)